Cargando…

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer

The histone methyltransferase SETD8, which methylates the lysine 20 of histone H4 (H4K20), is reportedly involved in human carcinogenesis along with nonhistone proteins such as p53. However, its expression profiles and functions in the context of high-grade serous ovarian carcinoma (HGSOC) are still...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Miku, Kukita, Asako, Sone, Kenbun, Hamamoto, Ryuji, Kaneko, Syuzo, Komatsu, Masaaki, Takahashi, Yu, Inoue, Futaba, Kojima, Machiko, Honjoh, Harunori, Taguchi, Ayumi, Kashiyama, Tomoko, Miyamoto, Yuichiro, Tanikawa, Michihiro, Tsuruga, Tetsushi, Mori-Uchino, Mayuyo, Wada-Hiraike, Osamu, Osuga, Yutaka, Fujii, Tomoyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766894/ https://www.ncbi.nlm.nih.gov/pubmed/33339442 http://dx.doi.org/10.3390/biom10121686

Ejemplares similares

The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells
por: Kukita, Asako, et al.
Publicado: (2022)

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
por: Kojima, Machiko, et al.
Publicado: (2019)

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
por: Kojima, Machiko, et al.
Publicado: (2020)

Characterization of a fluorescence imaging probe that exploits metabolic dependency of ovarian clear cell carcinoma
por: Tsuchimochi, Saki, et al.
Publicado: (2023)

MED1, a novel binding partner of BRCA1, regulates homologous recombination and R-loop processing
por: Honjoh, Harunori, et al.
Publicado: (2022)

Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications
por: Inoue, Futaba, et al.
Publicado: (2021)

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report
por: Sone, Kenbun, et al.
Publicado: (2020)

Recurrent malignant melanoma of the uterine cervix treated with anti-PD-1 antibodies and anti-CTLA-4 antibodies: A case report
por: Sone, Kenbun, et al.
Publicado: (2022)

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study
por: Ishizawa, Chihiro, et al.
Publicado: (2023)

A case of difficult‐to‐diagnose non‐invasive papillary squamous cell carcinoma of the uterine cervix infected with human papilloma virus 6: A diagnostic pitfall
por: Sone, Kenbun, et al.
Publicado: (2021)

Automated system for diagnosing endometrial cancer by adopting deep-learning technology in hysteroscopy
por: Takahashi, Yu, et al.
Publicado: (2021)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin
por: Nara, Katsuhiko, et al.
Publicado: (2023)

Cancer of unknown primary histologically, genetically and spatially diagnosed as left ovary‑derived cancer: A case report
por: Honjoh, Harunori, et al.
Publicado: (2023)

Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
por: Aotsuka, Aeri, et al.
Publicado: (2019)

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
por: Oki, Shinya, et al.
Publicado: (2017)

Suspicious Positive Peritoneal Cytology (Class III) in Endometrial Cancer Does Not Affect Prognosis
por: Sone, Kenbun, et al.
Publicado: (2022)

Effect of murine double‐minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys
por: Kawata, Yoshiko, et al.
Publicado: (2020)

Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study
por: Ishizaka, Aya, et al.
Publicado: (2022)

Evolution of a surgical system using deep learning in minimally invasive surgery (Review)
por: Sone, Kenbun, et al.
Publicado: (2023)

Development of a deep learning method for improving diagnostic accuracy for uterine sarcoma cases
por: Toyohara, Yusuke, et al.
Publicado: (2022)

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma
por: SATO, MASAKAZU, et al.
Publicado: (2016)

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer
por: Nara, Katsuhiko, et al.
Publicado: (2023)

Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma
por: Taguchi, Ayumi, et al.
Publicado: (2022)

Application of organoid culture from HPV18‐positive small cell carcinoma of the uterine cervix for precision medicine
por: Kusakabe, Misako, et al.
Publicado: (2023)

Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells
por: Fukuda, Tomohiko, et al.
Publicado: (2016)

Carcinogenesis and management of human papillomavirus-associated cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2023)

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary
por: Akino, Nana, et al.
Publicado: (2019)

Cells with stem‐like properties are associated with the development of HPV18‐positive cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2022)

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells
por: Takeuchi, Makoto, et al.
Publicado: (2019)

Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers
por: Yamaguchi, Kohei, et al.
Publicado: (2021)

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
por: Makii, Chinami, et al.
Publicado: (2016)

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin
por: Fukui, Yamato, et al.
Publicado: (2017)

Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
por: Taguchi, Ayumi, et al.
Publicado: (2023)

Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
por: Shoji, Keiko, et al.
Publicado: (2012)

Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging
por: Inaba, Kanako, et al.
Publicado: (2016)

Manual vacuum aspiration (women's MVA) for endometrial biopsy for patients with suspected endometrial malignancies
por: Saito, Etsuko, et al.
Publicado: (2022)

Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repair
por: Tanikawa, M, et al.
Publicado: (2013)

Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
por: Kashiyama, Tomoko, et al.
Publicado: (2014)

Identification of DBC1 as a transcriptional repressor for BRCA1
por: Hiraike, H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ql1v5uohthoc5v9i0a4mbsjk3k